MyoKardia, Inc. Common Stock
MYOK
MYOK was delisted on the 16th of November, 2020.
45 hedge funds and large institutions have $123M invested in MyoKardia, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 27 increasing their positions, 4 reducing their positions, and 3 closing their positions.
575% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 4
200% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 3
16% more capital invested
Capital invested by funds: $106M → $123M (+$16.9M)
15% more funds holding
Funds holding: 39 → 45 (+6)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.23M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$1.61M |
| 3 |
JP Morgan Chase
New York
|
+$1.33M |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
+$927K |
| 5 |
State Street
Boston,
Massachusetts
|
+$684K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$5.06M |
| 2 |
CC
Casdin Capital
New York
|
-$3.7M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$2.22M |
| 4 |
Millennium Management
New York
|
-$141K |
| 5 |
Citigroup
New York
|
-$49.6K |
MYOK Hedge Fund Activity: Q2 2016 in Review
45 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in MyoKardia, Inc. Common Stock (MYOK) for Q2 2016, worth a combined $123M — up 16% from $106M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MYOK positions and 3 closed out — a net gain of 6 holders — while 27 added to existing stakes and 4 trimmed.
The largest buyer was Vanguard Group, adding an estimated $2.23M. The largest seller was Driehaus Capital Management, cutting an estimated $5.06M.
- 45 institutional investors held MyoKardia, Inc. Common Stock (MYOK) as of Q2 2016, up from 39 in Q1 2016.
- Funds reported $123M of MyoKardia, Inc. Common Stock stock for Q2 2016, up 16% quarter-over-quarter.
- 9 funds opened new MyoKardia, Inc. Common Stock positions in Q2 2016 and 3 closed out, a net change of +6 holders.
- The largest MyoKardia, Inc. Common Stock buyer in Q2 2016 was Vanguard Group, an estimated $2.23M added.
- The largest MyoKardia, Inc. Common Stock seller in Q2 2016 was Driehaus Capital Management, an estimated $5.06M sold.
Based on aggregated 13F filings for Q2 2016.